Hikma and Glenmark Pharmaceuticals Enter into Exclusive Licensing Agreement for Commercialising Ryaltris™ Seasonal Allergic Rhinitis Nasal Spray in the US
Publish date unknown
/PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma, Group), the multinational generic pharmaceutical company, and Glenmark Specialty S.A., a Swiss subsidiary ...
Concept cloud
